Floatz logo

Cytarabine

Acute Monocytic Leukemia

Chinese PLA General HospitalSmall moleculePhase 3Active
BBB
78/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
70/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Acute Monocytic Leukemia cohort.

Asset / SponsorPhaseRating
Etoposide
Stanford University
Phase 3BBB
Daunomycin
National Cancer Institute (NCI)
Phase 3BBB
Cyclophosphamide
ECOG-ACRIN Cancer Research Group
Phase 3BBB
Nivestim
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3BBB
Mitoxantrone
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2/3BBB

View all 49 →

Same molecule, other indications

Cytarabine is also rated in:

acute promyelocytic leukemiaActive
A
Indicative · Phase 4
82 / 100
View asset →
adult acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 4
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative · Phase 3
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →